BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 25927504)

  • 1. Effects of strength training on body composition, physical functioning, and quality of life in prostate cancer patients during androgen deprivation therapy.
    Nilsen TS; Raastad T; Skovlund E; Courneya KS; Langberg CW; Lilleby W; Fosså SD; Thorsen L
    Acta Oncol; 2015 Nov; 54(10):1805-13. PubMed ID: 25927504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Football training improves lean body mass in men with prostate cancer undergoing androgen deprivation therapy.
    Uth J; Hornstrup T; Schmidt JF; Christensen JF; Frandsen C; Christensen KB; Helge EW; Brasso K; Rørth M; Midtgaard J; Krustrup P
    Scand J Med Sci Sports; 2014 Aug; 24 Suppl 1():105-12. PubMed ID: 24944134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of recreational football on bone health, body composition, and physical functioning in men with prostate cancer undergoing androgen deprivation therapy: 32-week follow-up of the FC prostate randomised controlled trial.
    Uth J; Hornstrup T; Christensen JF; Christensen KB; Jørgensen NR; Schmidt JF; Brasso K; Jakobsen MD; Sundstrup E; Andersen LL; Rørth M; Midtgaard J; Krustrup P; Helge EW
    Osteoporos Int; 2016 Apr; 27(4):1507-1518. PubMed ID: 26572756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance training and reduction of treatment side effects in prostate cancer patients.
    Galvão DA; Nosaka K; Taaffe DR; Spry N; Kristjanson LJ; McGuigan MR; Suzuki K; Yamaya K; Newton RU
    Med Sci Sports Exerc; 2006 Dec; 38(12):2045-52. PubMed ID: 17146309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can supervised exercise prevent treatment toxicity in patients with prostate cancer initiating androgen-deprivation therapy: a randomised controlled trial.
    Cormie P; Galvão DA; Spry N; Joseph D; Chee R; Taaffe DR; Chambers SK; Newton RU
    BJU Int; 2015 Feb; 115(2):256-66. PubMed ID: 24467669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of resistance training on body composition and metabolic syndrome variables during androgen deprivation therapy for prostate cancer: a pilot randomized controlled trial.
    Dawson JK; Dorff TB; Todd Schroeder E; Lane CJ; Gross ME; Dieli-Conwright CM
    BMC Cancer; 2018 Apr; 18(1):368. PubMed ID: 29614993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of a multi-component exercise programme and nutritional supplementation on musculoskeletal health in men treated with androgen deprivation therapy for prostate cancer (IMPACT): study protocol of a randomised controlled trial.
    Owen PJ; Daly RM; Livingston PM; Mundell NL; Dalla Via J; Millar JL; Fraser SF
    Trials; 2017 Oct; 18(1):451. PubMed ID: 28974267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer.
    Galvão DA; Spry NA; Taaffe DR; Newton RU; Stanley J; Shannon T; Rowling C; Prince R
    BJU Int; 2008 Jul; 102(1):44-7. PubMed ID: 18336606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term effects of androgen deprivation therapy in prostate cancer patients.
    Basaria S; Lieb J; Tang AM; DeWeese T; Carducci M; Eisenberger M; Dobs AS
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):779-86. PubMed ID: 12072048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized controlled trial on the effectiveness of strength training on clinical and muscle cellular outcomes in patients with prostate cancer during androgen deprivation therapy: rationale and design.
    Thorsen L; Nilsen TS; Raastad T; Courneya KS; Skovlund E; Fosså SD
    BMC Cancer; 2012 Mar; 12():123. PubMed ID: 22458865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time on androgen deprivation therapy and adaptations to exercise: secondary analysis from a 12-month randomized controlled trial in men with prostate cancer.
    Taaffe DR; Buffart LM; Newton RU; Spry N; Denham J; Joseph D; Lamb D; Chambers SK; Galvão DA
    BJU Int; 2018 Feb; 121(2):194-202. PubMed ID: 28872752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality of life in prostate cancer patients taking androgen deprivation therapy.
    Dacal K; Sereika SM; Greenspan SL
    J Am Geriatr Soc; 2006 Jan; 54(1):85-90. PubMed ID: 16420202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR.
    Galvão DA; Spry N; Denham J; Taaffe DR; Cormie P; Joseph D; Lamb DS; Chambers SK; Newton RU
    Eur Urol; 2014 May; 65(5):856-64. PubMed ID: 24113319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer.
    Alberga AS; Segal RJ; Reid RD; Scott CG; Sigal RJ; Khandwala F; Jaffey J; Wells GA; Kenny GP
    Support Care Cancer; 2012 May; 20(5):971-81. PubMed ID: 21538098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-intensity training following lung cancer surgery: a randomised controlled trial.
    Edvardsen E; Skjønsberg OH; Holme I; Nordsletten L; Borchsenius F; Anderssen SA
    Thorax; 2015 Mar; 70(3):244-50. PubMed ID: 25323620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endurance training improves insulin sensitivity and body composition in prostate cancer patients treated with androgen deprivation therapy.
    Hvid T; Winding K; Rinnov A; Dejgaard T; Thomsen C; Iversen P; Brasso K; Mikines KJ; van Hall G; Lindegaard B; Solomon TP; Pedersen BK
    Endocr Relat Cancer; 2013 Oct; 20(5):621-32. PubMed ID: 23744766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between circulating FSH levels and body composition and bone health in patients with prostate cancer who undergo androgen deprivation therapy: The BLADE study.
    Bergamini M; Dalla Volta A; Palumbo C; Zamboni S; Triggiani L; Zamparini M; Laganà M; Rinaudo L; Di Meo N; Caramella I; Bresciani R; Valcamonico F; Borghetti P; Guerini A; Farina D; Antonelli A; Simeone C; Mazziotti G; Berruti A
    Elife; 2024 Apr; 13():. PubMed ID: 38656229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate versus delayed exercise in men initiating androgen deprivation: effects on bone density and soft tissue composition.
    Taaffe DR; Galvão DA; Spry N; Joseph D; Chambers SK; Gardiner RA; Hayne D; Cormie P; Shum DHK; Newton RU
    BJU Int; 2019 Feb; 123(2):261-269. PubMed ID: 30239116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise Improves V˙O2max and Body Composition in Androgen Deprivation Therapy-treated Prostate Cancer Patients.
    Wall BA; GALVãO DA; Fatehee N; Taaffe DR; Spry N; Joseph D; Hebert JJ; Newton RU
    Med Sci Sports Exerc; 2017 Aug; 49(8):1503-1510. PubMed ID: 28319589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weight Loss for Obese Prostate Cancer Patients on Androgen Deprivation Therapy.
    Wilson RL; Newton RU; Taaffe DR; Hart NH; Lyons-Wall P; Galvão DA
    Med Sci Sports Exerc; 2021 Mar; 53(3):470-478. PubMed ID: 33009195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.